North Dakota to consider drug price transparency bill
If approved, the bill would require manufacturers to report the list price of the drugs they provide in North Dakota to the state four times each year. 6:13 pm, Jan. 7, 2021 ×
BISMARCK In an effort to lower the cost of prescription drugs across North Dakota, lawmakers are considering a bill that would require manufacturers to report the price of prescription drugs to the state.
The transparency bill, which was introduced to the North Dakota House Health Care Committee on Wednesday, Jan. 6, comes as drug prices nationwide are exponentially increasing. The bill, introduced by Legislative Management on behalf of the House Health Care Committee, would require drug manufacturers to report to the North Dakota Board of Pharmacy each quarter the list price of the approved drugs it sells in the state.